LifeStance Health (LFST) Revenue (2020 - 2026)

LifeStance Health has disclosed Revenue across 7 years of filings, most recently posting $403.5 million for Q1 2026.

• In Q1 2026, Revenue rose 21.17% year-over-year to $403.5 million; the TTM figure through Mar 2026 stood at $1.5 billion (up 16.46% YoY), while the FY2025 annual figure was $1.4 billion, up 13.85% from the prior year.
• Revenue grew to $403.5 million in Q1 2026, from $382.2 million in the prior quarter.
• Over the last five years, Revenue for LFST reached as high as $403.5 million in Q1 2026 and fell as low as $203.1 million in Q1 2022.
• The 5-year median for Revenue is $300.4 million (2024), against an average of $293.8 million.
• Annual changes were most pronounced in 2022 — Revenue soared 41.89% — and 2025, when it rose 10.56%.
• A 5-year view of Revenue shows it stood at $229.4 million in 2022, then climbed by 22.34% to $280.6 million in 2023, then rose by 15.99% to $325.5 million in 2024, then climbed by 17.43% to $382.2 million in 2025, then climbed by 5.57% to $403.5 million in 2026.
• According to Business Quant data, Revenue over the past three periods registered $403.5 million, $382.2 million, and $363.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.